Reinjection in Patients with Intraocular Inflammation Development after Intravitreal Brolucizumab Injection
This study elucidates the real-world incidence of brolucizumab associated IOIs, with a description of information related to reinjections after the IOI episodes. A comprehensive understanding of brolucizumab reinjection is essential for its optimal utilization.
Authors
- Soon Hyun Kim
- Myung Ae Kim
- Yong Sung You (ORCID: https://orcid.org/0000-0003-1297-8017)
- Oh Woong Kwon (ORCID: https://orcid.org/0000-0001-9786-6756)
- Soon Il Choi
- Ju Young Kim (ORCID: https://orcid.org/0000-0001-5762-6686)
- Jong Min Kim (ORCID: https://orcid.org/0000-0003-0906-0117)
- Won Ki Lee (ORCID: https://orcid.org/0000-0001-7039-1762)
- Hyun Sub Oh
Institutions
- Nune Eye Hospital (KR)
Publication Details
- Journal
- Korean Journal of Ophthalmology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3341/kjo.2024.0125
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71